Lydia Visser

8PUBLICATIONS
28CO-AUTHORS
Medical devicesPredictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 26, 2026
Structure-Function Analysis of Individual Reversion Variants of the Engineered Mpp46Aa1 (PS2Aa1) N65 Protein.

|Oct 25, 2024
Enhancing the Cytotoxicity and Apoptotic Efficacy of Parasporin-2-Derived Variants (Mpp46Aa1) on Cancer Cell Lines.

Juan S Alarcón-Aldana, Lydia Visser, Nohora J Rueda-Forero

|Apr 11, 2024
Small-Molecule Allosteric Inhibitors of Human Aspartate Transcarbamoylase Suppress Proliferation of Bone Osteosarcoma Epithelial Cells.

Chao Wang, Bidong Zhang, Yingying Cong

|May 27, 2023
Toxic Determination of Cry11 Mutated Proteins Obtained Using Rational Design and Its Computational Analysis.

Miguel O Suárez-Barrera, Diego F Herrera-Pineda, Paola Rondón-Villarreal

|Nov 26, 2022
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma.

Myra Langendonk, Nienke A M Smit, Wouter Plattel

|Nov 11, 2022
Site-Directed Mutants of Parasporin PS2Aa1 with Enhanced Cytotoxic Activity in Colorectal Cancer Cell Lines.

Miguel O Suárez-Barrera, Lydia Visser, Efraín H Pinzón-Reyes

Pageof 2

Frequent Collaborators

4 joint publications

Nohora Juliana Rueda-Forero

3 joint publications

Paola Rondón-Villarreal

3 joint publications

Miguel O Suárez-Barrera

2 joint publications

Arjan Diepstra